Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Biotechnology

Gradient Denervation Technologies

Martin Grasse

David Amaoua

This department oversees the strategic direction and policies of the organization through its board members.

Board Governance

This department is responsible for overseeing the planning, implementation, and management of clinical research and therapy development initiatives.

Clinical Development

This department oversees the overall strategic direction and operational management of the organization.

Executive Leadership

This department oversees validation and verification processes to ensure product quality and compliance during development.

Gradient Denervation Technologies

Org chart

Teams

Board Governance

Clinical Development

Executive Leadership

Quality Assurance

Offices

Gradient Denervation Technologies

Org chart

Teams

Board Governance

Clinical Development

Executive Leadership

Quality Assurance

Offices

Related companies